U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07437391) titled 'Effect of L-Carnitine Supplementation in Preterm Neonates' on Feb. 18.
Brief Summary: The current study is planned to see the effect of L-carnitine supplementation in preterm neonates suffering from RDS among the local population, as there is no such evidence available for the local population and there are conflicting statistics regarding the discharge rate of these neonates.
Study Start Date: Jan. 01
Study Type: INTERVENTIONAL
Condition:
Respiratory Distress Syndrome
Intervention:
DRUG: L-carnitine
Patients will receive L-carnitine at a therapeutic dosage of 30 mg/kg/day, in conjunction with a standard care regimen comprisi...